# NYVEPRIA

NDC: 0069-0324
Generic name: pegfilgrastim-apgf
Labeler / Manufacturer: Pfizer Laboratories Div Pfizer Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20201215

FDA application: BLA761111

## Active ingredients

- PEGFILGRASTIM: 6 mg/.6mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0069-0324"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0069-0324
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=99d30b99-2743-446b-98f3-0430bf4ea869